Viewing Study NCT02203851


Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2025-12-25 @ 9:44 PM
Study NCT ID: NCT02203851
Status: COMPLETED
Last Update Posted: 2019-11-08
First Post: 2014-07-29
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis
Sponsor: AbbVie
Organization: